Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 674 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX KOMISE X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

xx xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx xxx xxxxx xxxxxxxxxxxx vědeckotechnickému xxxxxxx xxxx nařízení Evropského xxxxxxxxxx a Rady (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx xxx EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx na Smlouvu x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,

x&xxxx;xxxxxxx xx nařízení Evropského xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 o klasifikaci, označování x&xxxx;xxxxxx xxxxx a směsí, x&xxxx;xxxxx a zrušení xxxxxxx 67/548/XXX a 1999/45/ES x&xxxx;x&xxxx;xxxxx xxxxxxxx (ES) č. 1907/2006 (1), x&xxxx;xxxxxxx xx xx.&xxxx;37 xxxx.&xxxx;5 uvedeného xxxxxxxx,

xxxxxxxx x&xxxx;xxxxx xxxxxxx:

(1)

Xxxxxxx 3 x&xxxx;xxxxx 3 přílohy XX xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxxxxx látek xx xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx X&xxxx;xxxxxxxxx xxxxxxxx.

(2)

Xxxxxxxx agentuře pro xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 předloženy xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx klasifikací x&xxxx;xxxxxxxx xxxxxxxxx jiných xxxxx. Xxxx, xx Výbor xxx xxxxxxxxxx rizik (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx, xxxxxx k těmto xxxxxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;(2):

—

xxxxxxxxxx xx xxx 5. prosince 2019 xxx xxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx amorfní xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx (XXX), [(3-fenoxy-4-fluorfenyl)kyanmethyl]-3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropan-1-karboxylát,

—

stanovisko xx xxx 4. května 2020 xxx β-xxxxxxxxxx (ISO); xxxxxxx xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-chlor-3-pyridyl)methyl]-N 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 pro tellur,

—

stanovisko xx xxx 11. června 2020 xxx xxxx xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx tribromderivát 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx piperonylbutoxid (XXX); 5-{[2-(2-butoxyethoxy)ethoxy]methyl}-6-propyl-1,3-benzodioxol,

—

stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxx,

—

xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2020 pro exo-1,7,7-trimethylbicyklo[2.2.1]hept-2-yl-akrylát; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—

stanovisko xx xxx 11. června 2020 pro xxxxxxxxxxx (XXX); 3,6-bis(o-chlorfenyl)-1,2,4,5-tetrazin,

—

stanovisko xx xxx 11. června 2020 xxx fluopikolid (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11. června 2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx soli,

—

stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxxxx xxxxxxxx {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctové kyseliny x&xxxx;xxxxxx pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx xxxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx chinoklamin (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17. září 2020 xxx toluen-4-sulfonohydrazid,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [m-TMXDI],

—

stanovisko xx xxx 17. září 2020 xxx 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [x-XXX],

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxx xxxxxxxx N-(2-nitrofenyl)fosforečné,

—

stanovisko ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 pro 2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; trimethylolpropan-triakrylát,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující &xx;&xxxx;0,1&xxxx;% xxxx. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším než 50 μx],

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥ 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx než 50 μx],

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxx amonný,

—

stanovisko ze xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxx-2-xxxxx-1-xxxx, sodnou xxx; xxxxxx sůl pyrithionu; xxxxxxxxx xxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8. října 2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 8. října 2020 xxx 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx xxx 8. října 2020 xxx xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); (2E)-2-{2-[(2,5-dimethylfenoxy)methyl]fenyl}-2-(methoxyimino)-N-methylacetamid; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid,

—

stanovisko xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 pro 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Disperse Blue 124,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx xxxxxxxxxxxxxxxxxx; xxxxxxxx tridekafluorheptanovou,

—

stanovisko xx xxx 10. prosince 2020 xxx methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; valifenalát,

—

stanovisko xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 pro 6-[xxxxx-(X10-X13, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanovou xxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro 6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx kyselinu,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; melamin,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx reakční xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx a 3-(difluormethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaftalen-5-yl]pyrazol-4-karboxamid [relativní xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxx, xxxxxxxx [x&xxxx;xxxxx rostliny Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx xxxxx x&xxxx;xxxx zpracovaný xxxxxxxxxxx xxxxxxxxxxxx],

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro xxxxxxxx (XXX), 3-xxxxxxxxx-2,1,3-xxxxxxxxxxxxxxx-4-xx-2,2-xxxxxx,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxx x&xxxx;xxxxxx inhalační xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) na xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx obdrženy xxxxxxxxx xxxxxxxxx, xxxxx xxxxxxxxxxx vědecké xxxxxxxxx xxxxxxx ve xxxxxxxxxxxx XXX xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-ethylhexanovou xxxxxxxx x&xxxx;xxxx soli; xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx komise, xx xxx 8. října 2020 xxx xxxxxx xxxxxx, xx dne 10. prosince 2020 xxx xxxx xxxxxxxxx, xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx opětovného posouzení xxxxxx informací o akutní xxxxxxxxx xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx komise x&xxxx;xx xxx 10. prosince 2020 xxx xxxxxxx.

(4)

Xxxxxx xxxx xxxxxxxxx informace xxxxxxxxx x&xxxx;xxxxxxxxxx xx xx xxxxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx ve stanoviscích XXX. Xx základě xxxxxxxxx provedeného v uvedených xxxxxxxxxxxx xx xxxxx xxxxxx zavést, xxxxxxxxxxxx xxxx zrušit harmonizovanou xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx.

(5)

Xxxx, co xxxx Xxxxxx xxxxxxx xxxxxxxxxx XXX, xxxx obdrženy xxxxxxxxx informace xxxxxxxx xx xxxxxx inhalační xxxxxxxx xxxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; pyrogenního syntetického xxxxxxxxx oxidu křemičitého x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx xxxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx oxidu křemičitého x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx 2, xxxxxxxxxx ve xxxxxxxxxx XXX ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019, by xxxxxx xxx zařazena xx xxxxxxx VI nařízení (XX) č. 1272/2008, xxxxx Xxxxxx nové xxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx, xx xx bylo xxxxx xxxxx xxxxxxxxx XXX. Xx přílohy XX xxxxxxxx (ES) x.&xxxx;1272/2008 xx xxxx xxxx být xxxxxxxx xxxxxxxxxxx xxxx xxxxx xxxx XXXX XX 2, xxxxxxxxxx xx xxxxxxxxxx výboru XXX xx xxx 5. prosince 2019, xxxxx xxxxxx xxxxxxxx xxxxx nové informace, xxxxx xx xxxxxxxxxx xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)

Xxxxxxxx (XX) x.&xxxx;1272/2008 xx proto xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx nových xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx nemělo xxx xxxxxxxxxx ihned, xxxxxxx xxxxxxxxxx xxxxxxxxx určitou xxxx xx xx, xxx xxxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx látek a směsí xxxxx nebo aktualizovaným xxxxxxxxxxxx x&xxxx;xxxxxxx stávající xxxxxx, na které xx vztahují předchozí xxxxxxxxxxx požadavky. Tato xxxx xx xxxxxx xxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxx xxxx dostatek xxxx xxxxxxxx xxxxxxxx xxxxx k zajištění xxxxxxxx xxxxxxxxxx dalších xxxxxxxx xxxxxxxxx, které xxxxxxxx x&xxxx;xxxxxxxx xxxx xxxxxxxxxxx xxxxx xxxxxx nařízení. Xxxxxxxxxxx xx však xxxx xxx xxxxxxxx xxxxxxxx xxxx nebo xxxxxxxxxxxxx harmonizované xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx způsobem xxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx xx xxxxxxxxxxx základě před xxxxx xxxxxxxxxxxxx tohoto xxxxxxxx, xxx byla xxxxxxxxx vysoká xxxxxx xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx xxxxxxxxx a aby xx xxxxxxxxxxx poskytla xxxxxxxxxx pružnost,

PŘIJALA TOTO XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx x&xxxx;xxxxxxx s přílohou xxxxxx xxxxxxxx.

Článek 2

Vstup x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx vstupuje v platnost xxxxxxxx xxxx xx xxxxxxxxx v Úředním xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx xx xxx dne 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx od xxxxxxx xxxxxxxxxxx xxxxxx článku xxxxx xxx xxxxx x&xxxx;xxxxx xxxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx s tímto xxxxxxxxx xxx dne xxxx vstupu v platnost.

Xxxx xxxxxxxx xx xxxxxxx v celém xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 16.&xxxx;xxxxx 2022.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX DER XXXXX

(1)&xxxx;&xxxx;Xx. věst. X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxxxx xxxx xxxxxxxx xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/. – Xxxxxxxxxx xx xxx 11. června 2020 x&xxxx;xx xxx 10. prosince 2020 xxxxxxxx xx xxxxxxxxxx posouzení xx xxxxxx Xxxxxxxx xxxxxx xxxx x&xxxx;xxxxxxxxx xx této xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

PŘÍLOHA

Příloha XX nařízení (XX) x.&xxxx;1272/2008 xx xxxx takto:

1)

v části 3 xx xxxxxxx 3 xxxx takto:

a)

vkládají xx xxxx xxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx CAS

Klasifikace

Označení

Specifické xxxxxxx. xxxxxx, multiplikační xxxxxxx a ATE

Poznámky

Kódy xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx o nebezpečnosti

Kódy xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx křemičitým; xxxxxxxxx xxxxxxxxxx amorfní xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx

272-697-1

68909-20-6

XXXX RE 2

X373 (plíce) (xxxxxxxxxx)

XXX08

Xxx

X373 (xxxxx) (xxxxxxxxxx)

XXX066“

„035-005-00-7

xxxxxx amonný

235-183-8

12124-97-9

Repr. 1X

Xxxx.

XXXX XX 3

XXXX XX 1

Xxx Xxxxx. 2

X360XX

X362

X336

X372 (xxxxxxx xxxxxx)

X319

XXX08

XXX07

Xxx

X360XX

X362

X336

X372 (xxxxxxx systém)

H319“

„050-032-00-4

dibutylcín-bis(2-ethylhexanoát)

220-481-2

2781-10-4

Muta. 2

Xxxx. 1X

XXXX RE 1

H341

H360FD

H372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Xxxx. 1X

XXXX XX 1

X341

X360XX

X372 (imunitní xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx telluričitý

231-193-1

7446-07-3

Repr. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„056-005-00-3

xxxxxxxxx xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1B

Acute Xxx. 4

Xxxxx Xxx. 3

X360XX

X332

X301

XXX08

XXX06

Xxx

X360XX

X332

X301

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 100&xxxx;xx/xx TH“

„601-097-00-8

propylbenzen

203-132-9

103-65-1

Flam. Xxx. 3

Xxx. Tox. 1

XXXX SE 3

Xxxxxxx Xxxxxxx 2

X226

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X304

X335

X411“

„603-243-00-6

xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Carc. 1B

Muta. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-butoxyethoxy)ethoxy]methyl}-6-propyl-1,3-benzodioxol

200-076-7

51-03-6

STOT XX 3

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H335

H319

H400

H410

GHS07

GHS09

Wng

H335

H319

H410

EUH066

M = 1

X&xxxx;= 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1X

Xxxxx Tox. 4

XXXX XX 2

Skin Xxxx. 1X

X360X

X302

X373 (xxxxx)

X317

XXX08

XXX07

Xxx

X360X

X302

X373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx TH“

„604-098-00-1

4,4’-sulfonyldifenol; xxxxxxxx S

201-250-5

80-09-1

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„606-153-00-5

xxxxxxxxxx

204-337-6

119-61-9

Xxxx. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (ISO); 2-amino-3-chlor-1,4-naftochinon

220-529-2

2797-51-5

Carc. 2

Xxxx. 2

Acute Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

Xxxx Sens. 1&xxxx;X

Xxxxxxx Acute 1

Aquatic Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, ledviny)

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H302

H373 (xxxxxx xxxx, xxxxxxx)

X319

X317

X410

xxxxxx:

XXX&xxxx;= 500 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„607-756-00-6

xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317“

„607-757-00-1

xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx

216-485-9

1596-84-5

Xxxx. 2

H351

GHS08

Wng

H351“

„607-758-00-7

4,4′-oxydi(benzensulfonohydrazid)

201-286-1

80-51-3

Self-react. X

Xxxxxxx Acute 1

Aquatic Xxxxxxx 1

H242

H400

H410

GHS02

GHS09

Dgr

H242

H410

M = 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. X

X242

XXX02

Xxx

X242“

„607-760-00-8

2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124

239-203-6

15141-18-1

Xxxx Xxxx. 1 A

H317

GHS07

Wng

H317

Skin Sens. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„607-761-00-3

xxxxxxxxxxxxxxxxx xxxxxxxx; xxxxxxxxxxxxxxxxxxxxx kyselina

206-798-9

375-85-9

Repr. 1X

XXXX XX 1

H360D

H372 (xxxxx)

XXX08

Xxx

X360X

X372 (játra)“

„607-762-00-9

methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; xxxxxxxxxxx

-

283159-90-0

Xxxx. 2

Xxxxxxx Chronic 2

X351

X411

XXX08

XXX09

Xxx

X351

X411“

„607-763-00-4

6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx

-

-

Xxxx. 1X

Xxx Xxxxx. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-764-00-X

6-[alkyl-(C10-C13, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanová xxxxxxxx

-

2156592-54-8

Xxxx. 1X

Xxx Xxxxx. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-765-00-5

6-[alkyl-(C12-C18, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanová kyselina

-

-

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (ISO); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

theofylin; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„613-343-00-1

xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100“

„613-344-00-7

xxxxxxx-2-xxxxx-1-xxxx, xxxxx xxx; xxxxx xxx pyrithionu; xxxxxxxxx xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Xxxxx Tox. 4

XXXX XX 1

Skin Xxxxx. 2

Eye Xxxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 2

X331

X311

X302

X372 (xxxxxxx systém)

H315

H319

H317

H400

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H302

H372 (xxxxxxx systém)

H315

H319

H317

H410

EUH070

inhalační:

ATE = 0,5 mg/l (xxxxx xxxx xxxx)

xxxxxxxx:

XXX&xxxx;= 790&xxxx;xx/xx TH

orální:

ATE = 500&xxxx;xx/xx XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-triazin-2,4,6-triamin;

melamin

203-615-4

108-78-1

Carc. 2

STOT XX 2

H351

H373 (xxxxxx xxxxx)

XXX08

Xxx

X351

X373 (xxxxxx xxxxx)“

„615-046-00-2

1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317“

„615-047-00-8

1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI]

222-852-4

3634-83-1

Resp. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Xxxx. 1&xxxx;X; X317: C ≥ 0,001 %“

„615-048-00-3

2,4,6-triisopropyl-m-fenylen-diisokyanát

218-485-4

2162-73-4

Resp. Xxxx. 1

Xxxx Xxxx. 1

H334

H317

GHS08

Dgr

H334

H317“

„615-049-00-9

1,5-diisokyanatonaftalen

[obsahující &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx]

221-641-4

3173-72-6

XXXX XX 3

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxx. Xxxx. 1

Skin Xxxx. 1&xxxx;X

Xxxxxxx Chronic 3

H335

H315

H319

H334

H317

H412

GHS07

GHS08

Dgr

H335

H315

H319

H334

H317

H412“

„615-050-00-4

1,5-diisokyanatonaftalen

[obsahující &xx;&xxxx;0,1&xxxx;% xxxx. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

XXXX XX 3

Xxxx Irrit. 2

Eye Xxxxx. 2

Xxxx. Sens. 1

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

H330

H335

H315

H319

H334

H317

H412

GHS06

GHS08

Dgr

H330

H335

H315

H319

H334

H317

H412

inhalační:

ATE = 0,27&xxxx;xx/x (xxxxx nebo xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-dichlor-N-[3-chlor-5-(trifluormethyl)-2-pyridyl]methylbenzamid

-

239110-15-7

Repr. 2

X361x

XXX08

Xxx

X361x“

„616-238-00-9

xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx

477-690-9

874819-71-3

Xxxx. 1B

STOT XX 2

X360Xx

X373 (xxxxxxx)

XXX08

Xxx

X360Xx

X373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; isoflucypram

-

1255734-28-1

Repr. 2

Xxxxx Xxx. 4

Skin Xxxx. 1X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X332

X317

X410

xxxxxxxxx:

XXX&xxxx;= 2,2&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 10

X&xxxx;= 1“

„616-240-00-X

reakční xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% anti-isomerů], isopyrazam

-

881685-58-1

Carc. 2

Xxxx. 1X

Xxxx Sens. 1X

Xxxxxxx Acute 1 Xxxxxxx Chronic 1

X351

X360X

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X360X

X317

X410

Xxxx. 1X; X360X:

X&xxxx;≥&xxxx;3&xxxx;%

X&xxxx;= 10

M = 10“

„650-058-00-1

Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx organickými xxxxxxxxxxxx]

283-644-7

84696-25-3

Xxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxxxx 1

H361d

H317

H410

GHS08

GHS07

GHS09

Wng

H361d

H317

H410

M = 10“

x)

xxxxxxx xxxxxxxxxxxx indexovým xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx xxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx název

Číslo XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx symbolů x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx doplň. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Xxx. 1

Xxxxx-xxxxx. 1

Acute Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxx. 1&xxxx;X

Xxx Dam. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;000 &xxxx;xx/xx TH“

„023-001-00-8

oxid xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Xxxx. 1B

Repr. 2

Xxxx.

Xxxxx Xxx. 3

Xxxxx Xxx. 2

STOT XX 3

XXXX RE 1

Aquatic Xxxxxxx 2

X341

X350

X361xx

X362

X301

X330

X335

X372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

XXX06

XXX08

XXX09

Xxx

X341

X350

X361xx

X362

X301

X330

X335

X372 (dýchací xxxxx, xxxxxxxxxx)

X411

xxxxxxxxx:

XXX&xxxx;= 0,05&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 220&xxxx;xx/xx XX“

„601-024-00-X

xxxxx

202-704-5

98-82-8

Xxxx. Liq. 3

Xxxx. 1X

Xxx. Tox. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

X226

X350

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X350

X304

X335

X411“

„603-014-00-0

2-xxxxxxxxxxx-1-xx; ethylenglykol-monobutyl-ether

203-905-0

111-76-2

Acute Xxx. 3

Acute Xxx. 4

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3 mg/l (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200 &xxxx;xx/xx XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether

203-906-6

111-77-3

Repr. 1X

X360X

XXX08

Xxx

X360X

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%“

„604-030-00-0

4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X

201-245-8

80-05-7

Xxxx. 1B

STOT XX 3

Xxx Xxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X315

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X315

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

X“

„607-230-00-6

2-xxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx, s výjimkou xxxx, xxxxx jsou xxxxxxx xxxxx x&xxxx;xxxx xxxxxxx

-

-

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„607-253-00-1

xxxxxxxxxx (ISO); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Xxx. 2

Acute Xxx. 2

STOT SE 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (prach nebo xxxx)

xxxxxx:

XXX&xxxx;= 14 mg/kg XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-254-00-7

β-xxxxxxxxxx (XXX); reakční xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

-

1820573-27-0

Xxxx.

Xxxxx Tox. 2

Xxxxx Tox. 2

XXXX XX 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H362

H330

H300

H370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 11 mg/kg XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxx. 1X

Xxxxx Xxx. 4

STOT XX 2

Xxx Xxxxx. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5 mg/l (xxxxx nebo mlha)“

„607-735-00-1

{[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctová xxxxxxxx

200-652-8

67-43-6

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

Eye Xxxxx. 2

X360X

X332

X373 (vdechování)

H319

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

X319

Xxxx. 1B; H360D: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

X360X

X332

X373 (vdechování)

GHS08

GHS07

Dgr

H360D

H332

H373 (vdechování)

Repr. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (prach xxxx xxxx)“

„608-032-00-2

xxxxxxxxxxx (ISO); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Xxx. 3

Xxxxxxx Xxxxxxx 1

Xxxxxxx Xxxxx 1

X361x

X301

X410

X400

XXX08

XXX06

XXX09

Xxx

X361x

X301

X410

xxxxxx:

XXX&xxxx;= 140&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

X&xxxx;= 10“

„613-012-00-1

bentazon (XXX); 3-isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-on-2,2-dioxid

246-585-8

25057-89-0

Repr. 2

Xxxxx Xxx. 4

Xxx Xxxxx. 2

Xxxx Xxxx. 1

H361d

H302

H319

H317

GHS08

GHS07

Wng

H361d

H302

H319

H317

orální: XXX&xxxx;= 1 600 &xxxx;xx/xx XX“

„616-164-00-7

xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Xxxx. 2

Acute Xxx. 4

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H332

H410

inhalační:

ATE = 1,3&xxxx;xx/x (prach nebo xxxx)

X&xxxx;= 100

X&xxxx;= 100“

c)

položka xxxxxxxxxxxx xxxxxxxxxx číslu 615-007-00-X xx xxxxxxx.